ClinicalTrials.gg
Drug

Gadolinium DTPA clinical trials

studies test it
8
open now
0
in phase 3
5
first study started
2003

How each study uses Gadolinium DTPA is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
2 Jun 1988 · MAGNEVIST · NDA 019596 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Gadopentetate dimeglumine (Magnevist)
3

Brand

Magnevist
1

Other names

gadopentetate dimeglumine
1

Studies by the year they started

8 studies that test it; most in 2003 (4)

Studies that test Gadolinium DTPA, by start year
YearStudies
20034
20041
20062
20071

By phase

A phase 1/2 study counts in both.

Phase 2
2
Phase 3
5
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 8 · Other 0

Bayer (6) · Bracco Diagnostics, Inc (2)

Often tested with

Tested in the same studies.

Gadobenic acid (2)

Studies

Open first, then newest update. How each study uses Gadolinium DTPA is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 8

Given beside what is tested · 1 — Gadolinium DTPA is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with Gadolinium DTPA

Codes

What other systems call Gadolinium DTPA · ClinicalTrials.gg INT008714

  • MeSH (NLM) D019786Gadolinium DTPAOne source NLM
  • UNII (FDA) K2I13DR72LGADOPENTETIC ACIDConfirmed FDA, NLM

Also registered as gadopentetate dimeglumine (UNII RH248G8V27 · RxNorm 25486).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.